DEC 18, 2019 8:47 AM PST

Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries

WRITTEN BY: Nouran Amin

Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of research is patience. At the end, results brought some light on understating pain levels in these kinds of injuries.

"Well, it doesn't seem to be working. I don't see any real change in pain behavior in any of the groups," said Shiga, a visiting scholar at University of California San Diego School of Medicine, apologetically, as he walked into the office of his supervisor, Wendy Campana, PhD, professor in the Department of Anesthesiology and Program in Neuroscience. "Although ... some rats are actually really moving."

What is different that time is researchers added a particular ‘stroke drug’ to the stem cell recipe before injecting into the rats spinal cord. The drug consists of a modified form of tissue-type plasminogen activator (tPA) used to target blood clots in non-hemorrhagic stroke and allows the blood and adequate oxygen to run freely into the brain post-stroke. In addition, TPA is a naturally occurring enzyme known to boost neuronal cell growth and lessen inflammation.

Findings were published in Scientific Reports and describes how researchers treated neuronal precursor cells referred to as progenitors with altered tPA.

"It was striking to see at two and four months the tremendous improvements in the ability of those progenitor cells to survive in the injury cavity," added Campana. "Just keeping these cells alive has been very difficult in past studies."

Learn more about spinal cord injuries:

"The addition of tPA-treated neural precursors didn't reduce pain in this model," Campana said. "But we also didn't exacerbate it -- and to not see increased pain is important safety information for clinical translation to improve motor outcomes. We also don't want worsen the pain burden of patients living with spinal cord injuries."

Source: Science Daily

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 04, 2022
Cannabis Sciences
Increasing Interest in Psychoactive Treatments for Mood Disorders
Increasing Interest in Psychoactive Treatments for Mood Disorders
Findings from various studies presented at the Society for Neuroscience 2022 annual meeting highlighted the need for inn ...
DEC 24, 2022
Drug Discovery & Development
Conflicting Data about use of PDE5 inhibitors in Alzheimer's Disease
Conflicting Data about use of PDE5 inhibitors in Alzheimer's Disease
There is a class of drugs called “Phosphodiesterase-5 inhibitors” (PDE5 inhibitors.) Such drugs in this clas ...
JAN 31, 2023
Drug Discovery & Development
Synthetic Cell Controls: The Only Way Forward for Flow Cytometry
Synthetic Cell Controls: The Only Way Forward for Flow Cytometry
 
JAN 10, 2023
Neuroscience
A Human Drug Improves the Recall of Lost Memories in Mice
A Human Drug Improves the Recall of Lost Memories in Mice
Staying up all night to prepare for an exam may not be much help to students, because memory can be impaired by many thi ...
JAN 18, 2023
Drug Discovery & Development
Slowing breast tumor growth with intravenous delivery of tumor suppressor genes
Slowing breast tumor growth with intravenous delivery of tumor suppressor genes
According to the American Cancer Society, breast cancer accounts for 30% of newly diagnosed invasive cancers in women. I ...
JAN 22, 2023
Neuroscience
Research Study Explores the Mysterious Causes of Pediatric Epilepsy
Research Study Explores the Mysterious Causes of Pediatric Epilepsy
Childhood epilepsy affects roughly 4% of the pediatric population, and there are many different types of epilepsy and se ...
Loading Comments...